Acute cerebellar syndrome after treatment by 5-fluorouracil;SYNDROME CEREBELLEUX AIGU APRES TRAITEMENT PAR LE 5-FLUOROURACILE

Bulletin du Cancer

Volumn 83, Issue 1, 1996, Pages 77-80

  Barbieux, C ^a   Patri, B ^a   Cerf, I ^a   De Parades, V ^a  

^a Hopital Boucicaut   (France)

Author keywords

5 fluorouracil; acute cerebellar syndrome

Indexed keywords

ALCOHOL; CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; PERIPHERAL NEUROPATHY; SQUAMOUS CELL CARCINOMA; ALCOHOLISM; CEREBELLAR ATAXIA; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG TOLERANCE; MIDDLE AGED; TONSIL TUMOR;

ALCOHOLISM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CEREBELLAR ATAXIA; CISPLATIN; DIAGNOSIS, DIFFERENTIAL; DRUG TOLERANCE; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; TONSILLAR NEOPLASMS;

EID: 0030071382     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aoki N. Reversible leucoencephalopathy caused by 5-fluorouracile derivates presenting as akinetic mutism. Surg Neurol 1986;25:279-82
2. Bemocchi B, Scherini E, Nano R. Developmental patterns in the rat cerebellum after cis-dichloro diammine platinum treatment. Neuroscience 1990;39:179-88
3. Boileau G, Piro AJ, Lahiri SR, Hall TC. Cerebellar ataxia during 5-fluorouracil (NSC-19893) therapy. Cancer Chemother Rep 1971;55:595-8
4. Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med 1989;321:442-54
5. Estrin WJ. Alcoholic cerebellar degeneration is not a dose-dependant phenomenon. Alcoholism (NY) 1987;11:372-5
6. Hook CC, Kimmel DW, Kvols LK et al. Multifocal inflammatory leucoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992;31:262-7
7. Hussain M, Wozniak AJ, Edelstein MB. Neurotoxicity of antineoplasic agents. Crit Rev Oncol Hematol 1993;14:61-75
8. Keer IG, Zimm S, Collins JM, O'Neill D, Poplack DG. Effect of intravenous dore and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the markey. Cancer Res 1984;44:4929-32
9. Kirnmel DW, Schutt AJ. Multifocal leucoencephalopathy: occurence during 5-Fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc 1993;68:363-5
10. Kleinschmidt-De Masters BK, Norenberg MD. Cerebellar degeneration in the rate following rapid correction of hyponatremia. Ann Neurol 1981;10:561-5
11. Koenig H, Patel A. Biochemical basis for fluorouracil neurotoxicity: ther role of Krebs cycle inhibition by fluoroacetate. Arch Neurol 1970;23:155-60
12. Krarup-Hansen A, Fugleholm K, Helweg-Larsen S et al. Examination of distal involement in cisplatin induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain 1993;116:1017-41
13. Lindenman G. Cisplatin neurotoxicity [Letter]. N Engl J Med 1990;323:64-5
14. Lo Monaco M, Milone M, Batocchi AP, Padual L, Restuccia D, Tonacip. Cisplatin neurotpathy: Clinical course and neurophysiological findings. J Neural 1992;239:199-204
15. Martinez Del Prado P, Meana JA, Carrion JR. Acute crerebrovascular accident after treatment with cisplatin. Acta Oncol 1992;31:593-5
16. Moertel CG, Reitemeier RJ, Bolton CF, Shorter RG. Cerebellar ataxia associated with fluorinated pyrimide therapy. Cancer Chemother Rep 1964;41:15-8
17. Moore DH, Fowler WCJR, Crumpler LS. 5-fluorocuracil neurotoxicity. Gynecol Oncol 1990;36:152-4
18. Okeda R, Shibutani M, Matsuo T, Kuroiwa T, Shimokawa R, Tajima T. Experimental neurotoxicity of 5-fluorouracil and its derivates is due to poisoning by the monofluorinated organic metabolites, monofluoretic acid and alphafluorobeta alanine. Acta Neuropathol 1990;81:66-73
19. Richl JL, Brown WJ. Acute cercbellar syndrom secondary to 5-fluorouracil therapy. Neurology 1964;14:961-7
20. Sebille A, St-Guily JL, Angelard B, De Stabenrath A. Low prevalence of cisplatin-induced neuropathy after 4 day continous infusion in head and neck cancer. Cancer 1990;65:2644-7
21. Siegal T, Haim N. Cisplatin induced peripheral neuropathy. Frequent off therapy deterioration, demyelinating syndromes, and muscles cramps. Cancer 1990;66:1117-23
22. Stenram U. 5-FU toxicity and nutritional deficiencies [Letter]. Br J Cancer 1993;67:1157
23. Van Gelder T, Geurs P, Khogs, Dippel DW, Vecht CJ, Splinter TA. Cortical blindness and seizures following cisplatin treatment: both of epileptic origin? [Letter]. Eur J Cancer 1993;29:1497
24. Victor M, Adams R, Mancall EL. A restricted form of cercbellar cortical degeneration occuring in alcoholic patients, Arch Neurol 1959;71:579-688
25. Weh HJ, Bittner S, Hoffknecht M, Hossfeld DK. Neurotoxicity following weekly therapy with folinic acid and high-dose 5-fluorouracil 24-h infusion in patient with gastro intestinal malignancies. Eur J Cancer 1993;29A: 1218-9